Cite
HARVARD Citation
Revenko, A. et al. (2022). Direct targeting of FOXP3 in Tregs with AZD8701, a novel antisense oligonucleotide to relieve immunosuppression in cancer. Journal for immunotherapy of cancer. 10 (4), p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Revenko, A. et al. (2022). Direct targeting of FOXP3 in Tregs with AZD8701, a novel antisense oligonucleotide to relieve immunosuppression in cancer. Journal for immunotherapy of cancer. 10 (4), p. . [Online].